In this feature from the British Medical Journal (BMJ), associate editor Peter Doshi explores the emerging research on immunological responses to COVID-19. Is it true that the human population had no pre-existing immunity to SARS-CoV-2? The article attempts to answer this question with a deeper discussion around herd immunity, T cells, antibodies, and more.
One expert credits a “good-enough strategy”; others worry that it will not last. This article explores Sweden’s victory in flattening its curve despite never implementing a full-scale lockdown. Although some claim triumph, others are questioning the cost of the strategy and the nation’s high death toll compared to its Scandinavian neighbors.
Data from the 1,459 patients who were African American, Hispanic, Native American, Pacific Islander, or Asian highlighted the need for increased surveillance for cutaneous toxicity in patients with darker pigmented skin. irCAEs were assessed by the Common Terminology Criteria for Adverse Events (CTCAE) v5.0.